LJPC - La Jolla Pharmaceutical Company

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5157.72M
Enterprise Value 3176.29M
Trailing P/E N/A
Forward P/E 1-1.94
PEG Ratio (5 yr expected) 1-0.11
Price/Sales (ttm)11.56
Price/Book (mrq)21.32
Enterprise Value/Revenue 312.92
Enterprise Value/EBITDA 6-1.08

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,233.15%

Management Effectiveness

Return on Assets (ttm)-56.12%
Return on Equity (ttm)-214.12%

Income Statement

Revenue (ttm)13.64M
Revenue Per Share (ttm)0.51
Quarterly Revenue Growth (yoy)443.30%
Gross Profit (ttm)-106.49M
EBITDA -163.68M
Net Income Avi to Common (ttm)-180.63M
Diluted EPS (ttm)-6.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)140.02M
Total Cash Per Share (mrq)5.17
Total Debt (mrq)155.5M
Total Debt/Equity (mrq)1,375.94
Current Ratio (mrq)8.65
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-139.2M
Levered Free Cash Flow (ttm)-79.27M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.90
52-Week Change 3-81.78%
S&P500 52-Week Change 33.91%
52 Week High 338.39
52 Week Low 35.01
50-Day Moving Average 37.17
200-Day Moving Average 38.73

Share Statistics

Avg Vol (3 month) 3612.51k
Avg Vol (10 day) 3533.1k
Shares Outstanding 527.1M
Float 17.16M
% Held by Insiders 16.08%
% Held by Institutions 1104.64%
Shares Short (Apr 30, 2019) 45.62M
Short Ratio (Apr 30, 2019) 414.82
Short % of Float (Apr 30, 2019) 433.89%
Short % of Shares Outstanding (Apr 30, 2019) 420.74%
Shares Short (prior month Mar 29, 2019) 45.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Jan 14, 2014